KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Stryker (SYK) EBITDA Margin (2016 - 2025)

Stryker (SYK) has disclosed EBITDA Margin for 17 consecutive years, with 25.16% as the latest value for Q4 2025.

  • On a quarterly basis, EBITDA Margin rose 1613.0% to 25.16% in Q4 2025 year-over-year; TTM through Dec 2025 was 19.47%, a 314.0% increase, with the full-year FY2025 number at 19.47%, up 314.0% from a year prior.
  • EBITDA Margin was 25.16% for Q4 2025 at Stryker, up from 18.74% in the prior quarter.
  • In the past five years, EBITDA Margin ranged from a high of 25.16% in Q4 2025 to a low of 9.03% in Q4 2024.
  • A 5-year average of 16.99% and a median of 17.73% in 2021 define the central range for EBITDA Margin.
  • Peak YoY movement for EBITDA Margin: skyrocketed 1777bps in 2021, then tumbled -1259bps in 2024.
  • Stryker's EBITDA Margin stood at 17.42% in 2021, then decreased by -10bps to 15.65% in 2022, then soared by 38bps to 21.62% in 2023, then plummeted by -58bps to 9.03% in 2024, then skyrocketed by 179bps to 25.16% in 2025.
  • Per Business Quant, the three most recent readings for SYK's EBITDA Margin are 25.16% (Q4 2025), 18.74% (Q3 2025), and 18.48% (Q2 2025).